Eli Lilly and Company

Associate Director - Clinical Operations Quality Assurance

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, Biotechnology, Medical ImagingIndustries

Requirements

The Associate Director, Clinical Operations Quality Assurance must have a strong understanding of Good Clinical Practice (GCP) Quality Management System (QMS) principles and regulatory risk management. Experience leading GCP QA activities and establishing functional QA procedures for sponsor oversight of internal operations and contracted clinical investigations is required. The role necessitates collaboration with cross-functional teams including Clinical Operations, Imaging Operations, Medical, and Statistics, as well as alignment with global Quality Management System (QMS) standards and corporate policies. A deep understanding of GCP inspection trends and experience in managing GCP QMS continuous improvement efforts are essential.

Responsibilities

This role is responsible for leading and managing the GCP external audit program, including designing procedures for sponsor QA responsibilities and site quality audits. The Associate Director will provide oversight and monitoring of investigational sites and third-party organizations, establishing risk-based quality oversight of GCP external organizations. They will support GCP operations in decision-making related to patient safety, efficacy data, and product quality, including deviation and CAPA management. Responsibilities also include evaluating the quality systems, operational controls, facilities, and personnel qualifications of potential third-party organizations. The role involves aligning and implementing global QMS standards, conducting internal audits and self-assessments, and educating personnel on GCP inspection trends. Continuous improvement of the GCP QMS, ensuring adequate procedures for document management, performance management, change control, deviations, complaints, computer systems, data integrity, risk analysis, training, and audit management are also key duties. Collaboration with team members to ensure visibility of performance and risks, and escalating performance issues to management are also required.

Skills

GCP Quality Management System (QMS)
Quality Assurance
Clinical Operations
Risk Management
Sponsor Oversight
Regulatory Compliance
Auditing
GCP
Clinical Investigations
Third-Party Oversight

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI